Faculty and Panel Members

Coordinating Chair
Fatima Cardoso Breast Unit, Champalimaud Cancer Center, Lisbon, PT
Chairs
Eric P. Winer Breast Oncology Center Dana-Farber Cancer Institute Boston, US	Larry Norton Breast Cancer Programs Memorial Sloan Kettering Cancer Centre New York, US	Alberto Costa European School of Oncology Milan IT and Bellinzona, CH
Co-Chairs
Elzbieta Senkus Department of Oncology and Radiotherapy Medical University of Gdansk, PL	Evi Papadopoulos Europa Donna Nicosia, CY
Scientific Committee Members
Matti S. Aapro IMO Clinique De Genolier Institut Multidisciplinaire d'Oncologie, Genolier, CH	Fabrice André Department of Medical Oncology Gustave Roussy Institute, Villejuif, FR	Nadia Harbeck Breast Center University of Munich, DE

Faculty

Bertha Aguilar Lopez
ULACCAM, Mexico City, MX

Carlos H. Barrios
Department of Medicine, PUCRS School of Medicine, Porto Allegre, BR

Jonas Bergh
Department of Oncology-Pathology, Karolinska Institute, Stockholm, SE

Elizabeth Bergsten Nordström
Swedish Breast Cancer Association, Stockholm, SE

Laura Biganzoli
Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, IT

Christine B. Boers-Doets
CB Boers ORG. Wormer, NL and The Netherlands Leiden University Medical Center, Leiden, NL

Anna Cabanes
Susan G. Komen, Washington, US

Maria João Cardoso
Breast Unit, Champalimaud Cancer Center and MamaHelp, Lisbon, PT

Lisa A. Carey
Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, North Carolina, US

Dian “CJ” m. Corneliussen-James
METAvivor Research and Support, Annapolis, US

Javier Cortés
Ramón y Cajal University Hospital, Madrid & Vall d’Hebron Institute of Oncology (VHIO), Madrid, ES

Giuseppe Curigliano
Division of Experimental Therapeutics, European Institute of Oncology, Milan, IT

Véronique Diéras
Gynaecology and Breast Department, Centre Eugène Marquis, Rennes, FR

Matthew J. Ellis
Lester and Sue Smith Breast Center, Baylor Clinic, Houston, US

Nagi S. El Saghir
NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, LB

Alexandru Eniu
Department of Breast Tumors, Cancer Institute “I. Chiricuta”, Cluj-Napoca, RO

Lesley Fallowfield
Sussex Health Outcomes Research & Education in Cancer, Brighton & Sussex Medical School, University of Sussex, Brighton, UK

Prudence A. Francis
Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, AU

Karen Gelmon
Department of Medical Oncology, BC Cancer Agency, Vancouver, CA

Mary K. Gospodarowicz
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, CA

Renate Haidinger
Brustkrebs Deutschland e.V., Munich, DE

Stephen R.D. Johnston
Breast, Lung & Medical Oncology Services CBU, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK

Gunes Kalkan
Breast Cancer Care, London, UK

Bella Kaufman
Oncology Institute, Sheba Medical Center, Tel Hashomer, IL

Smruti Koppikar
Department of Oncology, Bombay Hospital Institute of Medical Sciences, Lilavati Hospital and Asian Cancer Institute, Mumbai, IN

Ian E. Krop
Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US

Norbert Marschner
Department of Hematology and Oncology, Outpatient Cancer Center, Freiburg, DE

Musa Mayer
Metastatic Breast Cancer Alliance, New York, US

Shirley A. Mertz
Metastatic Breast Cancer Network US, Inverness, US

Gertrude Nakigudde
Uganda Women's Cancer Support Organisation, Kampala, UG

Birgitte V. Offersen
Department of Oncology, Aarhus University Hospital, DK

Shinji Ohno
Breast Oncology Centre, Cancer Institute Hospital, Tokyo, JP

Olivia Pagani
Breast Unit, Oncology Institute of Southern Switzerland, Bellinzona, CH

Shani Paluch-Shimon
Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, IL

Frédérique Penault-Llorca
Department of Pathology, Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, FR

Aleix Prat
Hospital Clínic of Barcelona, University of Barcelona, Barcelona, ES

Hope S. Rugo
Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, US

Timo Schinköthe
CANKADO, Munich, DE

George W. Sledge
Division of Oncology, Stanford School of Medicine, Stanford, US

Danielle Spence
Breast Cancer Network Australia, Camberwell, AU

Christoph Thomssen
Clinic for Gynaecology, Martin-Luther-Universität, Klinikum Kröllwitz, Halle (Saale), DE

Nicholas C. Turner
Breast Cancer Now Research Centre at the Institute of Cancer Research, London, UK

Daniel A. Vorobiof
Sandton Oncology Centre, Johannesburg, ZA

Nikhil Wagle
Harvard Medical School, Dana-Farber Cancer Institute, Boston, US

Binghe Xu
Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, CN

Consensus Panellist

Matti S. Aapro, CH
Bertha Aguilar Lopez, MX
Fabrice André, FR
Carlos H. Barrios, BR
Jonas Bergh, SE
Laura Biganzoli, IT
Christine B. Boers-Doets, NL
Fatima Cardoso, PT
Maria João Cardoso, PT
Lisa A. Carey, US
Javier Cortés, ES
Alberto Costa, IT/CH
Giuseppe Curigliano, IT
Véronique Diéras, FR
Nagi S. El Saghir, LB
Alexandru Eniu, RO
Lesley Fallowfield, UK
Prudence A. Francis, AU
Karen Gelmon, CA
Nadia Harbeck, DE
Stephen R.D. Johnston, UK
Bella Kaufman, IL
Smruti Koppikar, IN
Ian E. Krop, US
Musa Mayer, US
Gertrude Nakigudde, UG
Larry Norton, US
Birgitte V. Offersen, DK
Shinji Ohno, JP
Olivia Pagani, CH
Shani Paluch-Shimon, IL
Evi Papadopoulos, CY
Frédérique Penault-Llorca,FR
Aleix Prat, ES
Hope S. Rugo, US
Elzbieta Senkus, PL
George W. Sledge, US
Danielle Spence, AU
Christoph Thomssen, DE
Daniel A. Vorobiof, ZA
Eric P. Winer, US
Binghe Xu, CN

Breast Cancer Patient Advocacy Committee

Coordinator
Fatima Cardoso, Breast Unit, Champalimaud Cancer Center, Lisbon, PT

Bertha Aguilar Lopez, ULACCAM, Mexico City, MX
Anna Cabanes, Susan G. Komen, Washington, US
Maria João Cardoso, MamaHelp Association, Lisbon, PT
Dian “CJ” M. Corneliussen-James, METAvivor Research and Support, Annapolis, US
Gunes Kalkan, Breast Cancer Care, London, UK
Renate Haidinger, Brustkrebs Deutschland e.V., Munich, DE
Musa Mayer, Metastatic Breast Cancer Alliance, New York, US
Shirley A. Mertz, Metastatic Breast Cancer Network US, Inverness, US
Gertrude Nakigudde, Uganda Women's Cancer Support Organisation, Kampala, UG
Evi Papadopoulos, Europa Donna, Nicosia, CY
Danielle Spence, Breast Cancer Network Australia, Camberwell, AU

Disclosure of conflict of interest

Faculty members have been asked to disclose any potential conflict of interest in relation to their participation in the conference. Potential conflict of interest are considered any of the following: Any financial interest in or arrangement with a company whose products or services are discussed in the lecture or that might be considered as part of the consensus process. Any financial interest in or arrangement with a competing company. Any other financial relationship, direct or indirect, or other situations that might raise the question of bias in the work presenter or in the participation in the consensus process, including pertinent commercial or other sources of funding for the speaker or panellist or for the associated department or organisation,personal relationships or direct academic competition.

ABC4 Chairs, Co-Chairs, Scientific Committee Members, faculty and panel members

Matti S. Aapro: Receipt of grants/research supports: Amgen, Helsinn, Pfizer, Sandoz, TEVA, VIFOR. Receipt of honoraria or consultation fees: Amgen, Angelini, Helsinn, Kirin, Pfizer, Sandoz, Taiho, TEVA, VIFOR. Participation in a sponsored speakers’ bureau: Helsinn, Pfizer, Sandoz, Taiho, TEVA.
Bertha Aguilar Lopes: No significant relationships.
Fabrice André: Receipt of grants/research supports: AstraZeneca, Novartis, Pfizer, Lilly.
Carlos H. Barrios: Receipt of grants/research support: Pfizer, Novartis, Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Taiho Pharmacuetical, Mylan, Merrimack, Merck, Abbvie, Astellas Pharma, Biomarin, Bristol Myers Squibb, Daiichi Sankyo, Abraxis BioScience, AB Science, Asana Biosciences, Medivation, Exelius, ImClone Systems, LEO Pharma, Millenium. Receipt of honoraria or consultation fees: Boehringer Ingelheim, GSK, Novartis, Pfizer, Roche/Genentech, Eisai.
Jonas Bergh: Receipt of grants/research support: Amgen, AstraZeneca, Bayer, Merck, Pfizer, Roche, Sanofi-Aventis to Karolinska lnstitutet/University Hospital. No personal payments. Payment to Asklepios HB for a chapter in UpToDate on breast cancer.
Elizabeth Bergsten Nordström: No significant relationships.
Laura Biganzoli: Receipt of grants/research support: Celgene. Receipt of honoraria or consultation fees: Eisai, AstraZeneca, Ipsen, Roche, Novartis.
Christine B. Boers-Doets: Receipt of grants/research support: Bayer, Novartis, Pfizer, Roche, EusaPharma, Amgen, GSK. Amgen, AstraZeneca, Baxalta, Bayer, Becton, Dickinson, bioXtra, Boehringer Ingelheim, Bristol Myers Squibb, EusaPharma, Galera, GlaxoSmithKline, Helsinn, MerckSerono, Merck Sharp & Dohme, Shire, Nordic Pharma, Novartis, Pfizer, Roche, Takeda.
Anna Cabanes: Receipt of grants/research support: Pfizer Inc, Merck, Caterpillar, GE.
Fatima Cardoso: Receipt of honoraria or consultation fees: Astellas/Medivation, AstraZeneca, Celgene, Daiichi-Sankyo, Eisai, GE Oncology, Genentech, GlaxoSmithKline (GSK), Macrogenetics, Merck-Sharp, Merus BV, Mylan, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi, Teva.
Maria João Cardoso: No significant relationships.
Lisa A. Carey: No significant relationships.
Dian “CJ” M. Corneliussen-James: No significant relationships.
Javier Cortés: Receipt of honoraria: Roche, Novartis, Eisai, Celgene, Pfizer. Consulting/advisor: Roche, Celgene, Aztrazeneca, Cellestia Biotech, Biothera.
Alberto Costa: No significant relationships.
Giuseppe Curigliano: Receipt of honoraria or consultation fees: Roche, Pfizer.
Véronique Diéras: Receipt of honoraria or consultation fees for advisory boards: Roche, Novartis, Pfizer, Lilly, Abbvie. Participation in a sponsored speaker’s bureau: Roche, Pfizer.
Nagi S. El Saghir: Receipt of grants/research support: Novartis (to institution). Receipt of honoraria or consultation fees: Novartis, Roche, Pfizer, Lilly; MSD.
Matthew J. Elllis: Receipt of grants/research support: Pfizer. Receipt of honoraria or consultation fees: Pfizer, Astra Zeneca, Novartis, Puma. Stock shareholder: Bioclassifier LLC, Prosigna.
Alexandru Eniu: Receipt of grants/research support: Astra Zeneca, Roche, Celltrion, Pfizer.
Lesley Fallowfield: No significant relationships.
Prudence A. Francis: Receipt of honoraria or consultation fees: AstraZeneca. Other support: Overseas speaker for Pfizer.
Karen Gelmon: Receipt of grants/research support: AstraZeneca, Pfizer, BMS. Receipt of honoraria or consultation fees: Merck, AstraZeneca, Novartis, BMS.
Mary K. Gospodarowicz: No significant relationships.
Renate Haidinger: No significant relationships.
Nadia Harbeck: Receipt of honoraria or consultation fees: Amgen, Celgene, Novartis, Pfizer, Roche, Sandoz.
Stephen R.D. Johnston: Receipt of grants/research support: Pfizer, GlaxoSmithKline. Receipt of honoraria or consultation fees: AstraZeneca, Pfizer, Novartis. Participation in a sponsored speaker’s bureau: Pfizer, Puma, OBI.
Gunes Kalkan: No significant relationships.
Bella Kaufman: Not received.
Smruti Koppikar: Advisory board: Roche, Eli Lilly, Boehringer Ingelheim, MSD, Merck Serono, Myelan, Reddy.
Ian E. Krop: Receipt of grants/research support and receipt of honoraria or consultation fees: Genentech.
Norbert Marschner: Stock shareholder: Iomedico AG. Other support: Iomedico AG is supporter of the trial.
Musa Mayer: No significant relationships.
Shirley A. Mertz: Receipt of honoraria and consultation fees: Novartis, Pfizer.
Gertrude Nakigudde: Receipt of grants/research support: UICC SPACC grant, Pfizer.
Larry Norton: No significant relationships.
Birgitte V. Offersen: No significant relationships.
Shinji Ohno: Participation in a sponsored speaker’s bureau: AstraZeneca, Novartis, Chugai, Eisai, Taiho, Kyowa-Kirin.
Olivia Pagani: No significant relationships.
Shani Paluch-Shimon: No significant relationships.
Evi Papadopoulos: No significant relationships.
Frédérique Penault-Llorca: Receipt of grants/research support: Roche, BMS, AstraZeneca. Receipt of honoraria or consultation fees: Roche, Novartis, BMS, AstraZeneca, MSD.
Aleix Prat: Receipt of honoraria or consultation fees: Nanostring technologies.
Hope S. Rugo: Receipt of grants/research support: Genentech/Roche, Novartis, Eisai, OBI, Plexxikon, Merck, Macrogenics, Pfizer, Lilly.
Timo Schinköthe: No significant relationships.
Elzbieta Senkus: Receipt of grants/research support: Amgen, Astellas, AstraZeneca, Bayer, BMS, Janssen, Pfizer, Pierre Fabre, Roche. Other support (travel expenses) Amgen, Astellas, AstraZeneca, Bayer, BMS, Janssen, Pfizer, Novartis, Roche.
George W. Sledge: Receipt of honoraria or consultation fees: Symphogen. Stock Shareholder: Syndax.
Danielle Spence: No significant relationships.
Christoph Thomssen: Receipt of honoraria and consultation fees: Amgen, Astra Zeneca, Celgene, Nanostring, Novartis, Pfizer, Roche.
Nicholas C. Turner: Not received.
Daniel A. Vorobiof: Receipt of honoraria and consultation fees: Pfizer, BMS, MSD, AstraZeneca, Eisai, Roche. Participation in a sponsored speaker’s bureau: BMS, MSD, Roche.
Nikhil Wagle: Receipt of grants/research support: Novartis, Merck, Puma. Receipt of honoraria and consultation fees: Novartis, Grail. Stock shareholder: Foundation medicine.
Eric P. Winer: Receipt of grants/research support: Genentech. Receipt of honoraria and consultation fees: Genentech, Tesaro. Advisory board: Leap.
Binghe Xu: No significant relationships.